Jpmorgan Chase Stock News

Chesley Taft & Associates LLC lifted its holdings in shares of JPMorgan Chase & Co. (NYSE:JPM) by 0.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 207,269 shares of the financial services providers stock after buying an additional 1,765 []

Thomasville National Bank boosted its holdings in shares of JPMorgan Chase & Co. (NYSE:JPM) by 3.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 172,828 shares of the financial services providers stock after acquiring an additional 5,754 shares during the []

M&R Capital Management Inc. raised its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 0.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 56,015 shares of the financial services providers stock after acquiring an additional 188 shares during the []

JPMorgan Chase & Co. raised its holdings in shares of Altisource Portfolio Solutions S.A. (NASDAQ:ASPS) by 108.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 28,489 shares of the business services providers stock after buying an additional 14,806 shares during the quarter. JPMorgan Chase & Co.s holdings in Altisource Portfolio Solutions were worth []

JPMorgan Chase & Co. acquired a new position in Alliance Resource Partners, L.P. (NASDAQ:ARLP) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 34,888 shares of the energy companys stock, valued at approximately $252,000. A number of other institutional investors have also made changes to []

JPMorgan Chase & Co. increased its holdings in shares of Liberty Media Acquisition Co. (OTCMKTS:LMACU) by 142.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,242 shares of the companys stock after acquiring an additional 14,242 shares during the []

JPMorgan Chase & Co. purchased a new position in shares of G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 60,164 shares of the companys stock, valued at approximately $221,000. Shares of NASDAQ GMVD opened at $2.08 []

JPMorgan Chase & Co. lessened its position in Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) by 40.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,160 shares of the asset managers stock after selling 11,480 shares during the period. JPMorgan Chase & []

JPMorgan Chase & Co. boosted its position in Navigator Holdings Ltd. (NYSE:NVGS) by 15.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,377 shares of the shipping companys stock after buying an additional 3,201 shares during the period. JPMorgan []

JPMorgan Chase & Co. lifted its holdings in Celcuity Inc. (NASDAQ:CELC) by 234,200.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,372 shares of the companys stock after purchasing an additional 9,368 shares during the quarter. JPMorgan Chase & Co.s holdings in Celcuity []

JPMorgan Chase & Co. lessened its holdings in Gatos Silver, Inc. (NYSE:GATO) by 80.8% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,289 shares of the companys stock after selling 55,969 shares during the period. JPMorgan Chase & Co.s holdings in Gatos Silver were []

JPMorgan Chase & Co. increased its stake in Chimerix, Inc. (NASDAQ:CMRX) by 26.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,240 shares of the biopharmaceutical companys stock after purchasing an additional 5,926 shares during the period. JPMorgan Chase & Co.s holdings []

JPMorgan Chase & Co. reduced its stake in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) by 43.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 59,786 shares of the companys stock after selling 46,316 shares during the quarter. JPMorgan Chase & Co.s holdings in Cyclerion Therapeutics were []